Transition of Care, Part 2: Logistics, Costs, and Self-Advocacy
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Transition of Care, Part 2: Logistics, Costs, and Self-Advocacy
-
ナレーター：
-
著者：
このコンテンツについて
In part 2, we get practical: planning treatment around family calendars and holidays, deciding between inpatient and outpatient treatment, arranging travel and temporary housing, syncing records between centers, getting financialassistance, and advocating for yourself. With insights from Dr. Joshua Dower (Stamford Health) and lived experiences from myeloma patients Kim and Annie, this episode is your playbook for navigating the details.
Topics of discussion:
(01:13) Navigating travel and scheduling for CAR T-cell therapy
(06:02) Navigating travel and scheduling for bispecific antibody therapy
(09:25) Support from the care team
(11:23) Advocating for the best possible care during transition of care
This episode is supported by Pfizer Inc.
To learn more about bispecific antibody and CAR T-cell therapy, download the Immunotherapy booklet here.
To learn more about multiple myeloma, visit themmrf.org.
To learn more about the MMRF’s FREE resources for patients and caregivers, visit the MMRF Education Hub.
If you have additional questions, call our MMRF Patient Navigation Center at 1-888-841- 6673.